Navigation Links
Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th
Date:6/3/2008

.nephros.com" target="_new">http://www.nephros.com.

Forward-Looking Statements

Statements in this news release that are not historical facts constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "PSLRA"). Such statements may be preceded by words such as "may," "plans," "expects," "believes," "hopes," "potential" or similar words. For such statements, Nephros claims the protection of the PSLRA.

Forward-looking statements are not guarantees of future performance, are based on assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond Nephros's control. Actual results may differ materially from the expectations contained in the forward-looking statements. Factors that may cause such differences include the risks that Nephros may not be able: (i) to obtain funding if and when needed or on favorable terms; (ii) to continue as a going concern; (iii) to liquidate its short-term investments when needed to fund its operations; (iv) to maintain compliance with the AMEX's continued listing standards; (v) to demonstrate in pre-clinical or clinical trials the anticipated efficacy, safety or cost savings of products that appeared promising to Nephros in research or clinical trials; (vi) to obtain appropriate or necessary governmental approvals to achieve its business plan or effectively market its products; (vii) to have its technologies and products accepted in current or future target markets; or (viii) to secure or enforce adequate legal protection, including patent protection, for its products. More detailed information about Nephros and the risk factors that may affect the realization of forward-looking statements is set forth in Nephros' filings with the SEC, including Nephros' Annual Report on Form 10-KSB filed with the SEC for the fiscal year ended December 31, 2007, and Nephros' Quarterly Report on Form 10-Q for the period ended March
'/>"/>

SOURCE Nephros, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nephros Strengthens Commercialization Team with Addition of Marketing Executive
2. Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008
3. Nephros Reports 2008 First Quarter Financial Results
4. Announcing Always Best Care Senior Services Expansion Into the Littleton/Denver, Colorado Area
5. CRH Medical Corporation opens new center in Denver, Colorado
6. Latest Advances in Infection Prevention and Control to be Presented in Denver, CO at Worlds Largest Annual Infection Prevention Conference, June 15-19, 2008
7. Colorado Medical School Receives Provisional Accreditation
8. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
9. Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards
10. Colorado Doctors of Chiropractic Win Awards
11. Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...nsider change after 30-minute psychosocial interve...HealthDay News) -- A program that gets persistent ...ir dangerous behavior may lead to significant and ... The new study included 184 men and women with two...ere randomly assigned to one of two interventions....
(Date:11/27/2009)...Replikins Ltd. today issued its latest biochemical...s that the lethality of the virus has dropped from...rent outbreak in the spring of 2009 to resting non...H1N1 infectivity count, however, remains increased...er 27, 2009 -- Biotech firm Replikins Ltd., which ...
(Date:11/27/2009)... 27 Shamir Optical Indus...provider of innovative products and technology to ...ts board of directors had declared a dividend dist...(approximately NIS 37.62 million based on the Nove... approximately US$ 0.609 (approximately NIS 2.3 ba...
(Date:11/27/2009)...™ announced today that Spectrum Health (Gran...erprise orthopedic templating solution and its Tra... (PRWEB) November 27, 2009 -- Voyant Heal...and Rapids, Michigan) has licensed its TraumaCad E...raumaCad Extend workflow solution, to allow its or...
(Date:11/26/2009)... The diabetes population in the Uni...rs and annual medical spending on the disease is p... today, according to a study published in the Dece...ging Diabetes ® Program (NCDP), a program of ...from the University of Chicago. ,, According to...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...ng to the parliament's Health Select Committee the...England needs to be reviewed//. It pointed out...entistry and eye care do not have any comprehensib...t on the patients and the evidence for this fact i...
...eturning from malaria-prone Garo Hills region, Meg...alised with symptoms of the same disease. // ...ay, was admitted to the civil hospital here with m...ict town Tura. Malaria had claimed 40 lives i...
...o Kills/Smoking Kills" -- such health warnings wou...ng which the sellers would attract stringent penal...arnings that could appear on tobacco packages incl...ry headed by Anbumani Ramadoss, who has been a sta...
...ot uncommon to have testimonies of surgeries - ins... patients' bodies, a stark reminder of medical// n...s and even death of unfortunate patients. Statisti...named as the 'magic wand' which will ensure surgeo...
...ot healthy to lose weight soon after giving birth,... being advised about the pitfalls of following cel...gure soon after child birth, which can have seriou...trition levels in both the mother and the baby. A ...
...ury University researcher Dr Victoria Metcalf is o...rs about fish. Metcalf will use the genetic filter...bolize fat. This study will aid in the understandi...ans who get the energy from carbohydrates. In her ...
Other Medicine News:
(Date:11/25/2009)..., , WESTON, Fla., Nov. 25 /PRNewswire...(Pink Sheets: ASFX) ("the Company") is pleased to ...g and production management office in Shanghai, Ch...abroad, providing an essential gateway for the dev...th and safety products for children and adults to ...
(Date:11/25/2009)..., , CHICAGO and STAFA, Switzerland, Nov. 25... leading manufacturer of innovative hearing soluti...are for Adults Conference, focusing on the special...ught together leading experts in aging and audiolo...ans who work everyday with older people with heari...
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNews...ary of American Pacific Corporation (Nasdaq: APFC...tal Responsibility and Sustainability Award at the...by the California Manufacturers and Technology Ass...ciation (IEA) and the Chemical Industry Council of...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Census Bureau to Announce Findings for Income Earnings Poverty and Health Insurance Coverage 56596 1Census Bureau to Announce Findings for Income Earnings Poverty and Health Insurance Coverage 56596 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 1Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 4Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 5Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 6Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 7Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 8Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 9PDL BioPharma to Present at BioCentury Newsmakers Conference on September 16 2009 56592 1
...achour, MD, FACC, director of interventional cardi... results of a study at the American Heart,Associat...lynews.com/tuesday.pdf ) meeting in Orlando showin...efore a heart attack,patient arrives improves door... after hours. Door-to-balloon time is measured fro...
... observed through 2.5 years of LymphoStat-...observed increase in rates of adverse events, seri...over 2.5 years of LymphoStat-B treatment -, ROCKV...daq: HGSI ) today announced the presentation of P...tat-B(R) (belimumab) achieved a sustained,improvem...
Other Medicine Technology:Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients 2Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 8
Rongeur #4
Cleveland Rongeur #4A
Rongeur #260
Ruskin Mini-Bone Rongeur
Medicine Products: